We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


ProBioGen and Life Technologies Present Freedom™ CHO-S™ Platform

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "ProBioGen and Life Technologies Present Freedom™ CHO-S™ Platform"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

ProBioGen AG and Life Technologies Corporation announce the launch of the new Freedom™ CHO-S™ Kit as the result of a successful co-development.

The kit was built for developing stable high yield production cell lines in less than 4 months, and is based on Life Technologies’ CHO-S™ Cells.

The Freedom™ CHO-S™ Kit platform enables end-users the cost- and time-efficient creation of stable cell lines for research and commercial purposes.

The kit’s applicability and efficiency was confirmed in several studies, in which antibody titers of 1 to 3 g/L have been obtained.